SCHEMBL5582320

SCHEMBL5582320

COc1ccc2c(c1)CC1(Cc3ccc(Cl)cc3)CCC(=O)C(Br)=C21

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 18/20 0.59
ESR2 Q92731 17/20 0.53
PRNP P04156 1/20 0.52
UTS2R Q9UKP6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5582427 0.83 ESR1 (0.68) ESR1ESR2
SCHEMBL5582338 0.81 ESR1 (0.61) ESR1ESR2PRNP
SCHEMBL5582489 0.80 ESR2 (0.60) ESR1ESR2UTS2R
SCHEMBL2417960 0.80 ESR2 (0.73) ESR1ESR2PRNP
SCHEMBL14524720 0.78 ESR2 (0.73) ESR1ESR2
SCHEMBL2417699 0.76 PRNP (0.81) ESR1ESR2PRNP
SCHEMBL4856450 0.75 PRNP (0.69) ESR1ESR2PRNP
SCHEMBL4858819 0.74 ESR2 (0.62) ESR1ESR2PRNP
SCHEMBL14339932 0.70 ESR2 (0.71) ESR1ESR2
SCHEMBL2418485 0.69 ESR2 (0.57) ESR1ESR2PRNP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070087346-A1 Orthogonal gene switches CILIBERTO GENNARO 2007-04-19 US disclosed
US-20070087346-A1 Orthogonal gene switches CILIBERTO GENNARO 2007-04-19 US disclosed
US-20070087346-A1 Orthogonal gene switches CILIBERTO GENNARO 2007-04-19 US disclosed
EP-1680447-A2 ORTHOGONAL GENE SWITCHES ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2006-07-19 EP disclosed
WO-2005040212-A2 ORTHOGONAL GENE SWITCHES ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI SPA (IT) 2005-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070087346-A1 Orthogonal gene switches TCF12, JUN, TCF7 ESR1 329/4885ESR2 280/4885PRNP 4594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.